Brimonidine for Intraoperative Hemostasis

• Status: Recruiting
• Trial end date: 2022-12-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to observe and report the effects of topical ophthalmic brimonidine in oculofacial plastic surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Louisville
• Treatments: Brimonidine Tartrate

Criteria

Inclusion Criteria:

• Above the age of 18

• Ophthalmic conditions requiring oculoplastic surgery

Exclusion Criteria:

• Known allergy or adverse effects to brimonidine

• Hypotony

• Acute ophthalmic infection

• History of hypotension

• Orthostatic hypotension

• Pregnancy

• History of Central Nervous System (CNS) depression from medication use

• Thrombotic disorders

• Asymmetrical oculoplastic conditions that may interfere with tear drainage (e.g. unilateral NLDO)

• Current use of brimonidine